News from the global scientific community focused on furthering the understanding and treatment of pediculosis, including research and clinical trials. |
The Public Health Medicine Environmental Group (PHMEG) has recently released updated guidelines for diagnosis, preventation and treatment of head lice infection. This is a revised version of the 2008 update.
A newly-published review paper in the April 2012 edition of Clinical Microbiological Infection discusses the spread of insecticide resistance and the effect on head lice treatment.
A new study of the NYDA dimeticone series, published in the March 2012 edition of the Journal of Medical Entomology, has shown complete ovidical effectiveness in in vitro experiments.
A large-scale survey of household lice inspection in Norway has found that nearly half of households inspect for head lice either biannually or not at all.
Pediculosis is the subject of two new recent comment papers (subscription required for access).
A round-up of literature over the last couple of years covering diverse methods of treating pediculosis.
Physically acting pedulicides are of continuing interest to the those creating and providing anti-head lice treatments. In particular, dimeticones have received increasing attention over the last few years. Here we summarise the results in the scientific literature between 2010 and now.
The Cochrane Collaboration has released an updated protocol for assessing the effectiveness of head-lice treatments by means of meta-studies of Randomized Controlled Trials, as part of an update to their review of evidence for the effectiveness of pediculosis treatments.
Could anti-headlice shower caps be the future for headlice treatment?
Spinosad has been the topic of two recent papers investigating its effectiveness in treating pediculosis in humans.